Wednesday, June 10, 2026

pharma Β· Phenylketonuria Β· Amyotrophic Lateral Sclerosis Β· PTCT

PTC THERAPEUTICS

PTC THERAPEUTICS clinical programs β€” 52 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

500 Warren Corporate Center Drive, Warren, NJ 07059, US HQ
1998 Founded
1,153 Employees
Public company Type
PTCT Β· NYSE Ticker
Company details
Status
Public
HQ
500 Warren Corporate Center Drive, Warren, NJ 07059, US
Founded
1998
Employees
1,153
Programs
52
Drugs
21
Patents
149
Intelligence Β· Clinical Programs

PTC THERAPEUTICS projects

52 ClinicalTrials.gov programs sponsored by PTC THERAPEUTICS.

PTC THERAPEUTICS has 52 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

Page 2 of 2
  1. PTC596

    PTC THERAPEUTICS, INC.

    Cancer

    phase 1 small molecule completed

    1 trial
  2. PTC596

    PTC THERAPEUTICS, INC.

    High Grade Glioma

    phase 1 small molecule active

    1 trial
  3. Unesbulin

    PTC THERAPEUTICS, INC.

    Ovarian Cancer

    phase 1 small molecule completed

    1 trial
  4. VEGF inhibitor PTC299

    PTC THERAPEUTICS, INC.

    Brain and Central Nervous System Tumors

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does PTC THERAPEUTICS have?

52 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.